跳至主要内容
临床试验/TCTR20240805004
TCTR20240805004已完成2 期

Fecal Microbiota Transplantation Enema as a Noval Approach for Metabolic Syndrome: An Investigator-Initiated Randomized Sham-Intervention Study

The Gastroenterological Association of Thailand (GAT)0 个研究点目标入组 18 人开始时间: 2024年8月5日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 70 Years(—)
性别
All

入选标准

  • Adults aged 20-70 diagnosed with MetS according to the standards of the International Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute.

排除标准

  • Exclusion criteria included severe chronic conditions such as end-stage kidney disease (with or without renal therapy), hepatic cirrhosis (Child-Pugh B/C), congestive heart failure, types 1 or 2 diabetes, immunodeficiency disorders, and use of immunosuppressants, chemotherapy, antibiotics, pre-/probiotics, or experimental drugs within the last 12 weeks. Other exclusions were prior gastrointestinal surgery affecting the anatomy, smoking, pregnancy, and breastfeeding.

研究者

相似试验